Dual FAAH and MAGL inhibition might play a key role in visceral pain.

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Turkish Journal of Gastroenterology

• Publication date

  2018-08-31

• Fields of study

  Medicine

• Identifiers
  DOI 10.5152/tjg.2018.18401PMID 30260791PMCID PMC6284613
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The cannabinoid system and pain

  2017cited by this paper
• The effect of FAAH, MAGL, and Dual FAAH/MAGL inhibition on inflammatory and colorectal distension‐induced visceral pain models in Rodents

  2015cited by this paper
• Estimates of pain prevalence and severity in adults: United States, 2012.

  2015cited by this paper
• Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine inflammatory pain model.

  2014cited by this paper
• Recent Advances in the Pharmacological Management of Pain

  2012cited by this paper
• The endocannabinoid system and pain.

  2009cited by this paper
• Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo

  2009cited by this paper

• Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition

  2022cites this paper
• Potential application of endocannabinoid system agents in neuropsychiatric and neurodegenerative diseases—focusing on FAAH/MAGL inhibitors

  2020cites this paper
• Druggable Targets of the Endocannabinoid System: Implications for the Treatment of HIV-Associated Neurocognitive Disorder.

  2019cites this paper